vcvibes

Red Tree Management, LLC

SEC exempt reporting adviser (venture capital exemption).

HQ
CA

Red Tree Management, LLC is home to Red Tree Venture Capital, an early stage-biased life science venture firm. It focuses on therapeutics in oncology, neurology, and immunology, with selective medical device investments. Co-founders Heath Lukatch, Ph.D. and Jennifer Cochran, Ph.D. lead the firm. Portfolio companies include Rondo Therapeutics, Bicara Therapeutics, Magnus Medical, and Ceribell.

01 · Says / Does

TagSaysDoes
StagesSeed, Series ANot enough dated deals
SectorsBiotech, Medical devicesNot enough dated deals
RegionsCA, OR, WANot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Red Tree Venture Fund II, L.P.

Red Tree Venture Capital is an early stage-biased life science venture firm. It invests in first-in-class and best-in-class therapeutics in oncology, neurology, and immunology, and selectively funds medical device companies. It sources deals from West Coast academic and research institutions and often leads or co-leads rounds. Inferred from the firm's website

2024$133.27M to $350M (Form D)Open, writing first checks
Red Tree Venture Fund, L.P.2020$176.66M to $274.42M (Form D and SEC adviser filing)Follow-ons only

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://redtreevc.com
  2. https://redtreevc.com/team/
  3. https://redtreevc.com/about-us/
  4. https://redtreevc.com/news/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026